Wall Street analyst estimates for Impact BioMedical Inc. (IBO): consensus price target, buy/hold/sell recommendations and forecasts for revenue, EPS and EBITDA for the upcoming fiscal years.
Houston, Texas-based Impact BioMedical Inc., founded in 2018, focuses on discovering and developing innovative products and therapeutic options for both specialty biopharmaceuticals and consumer healthcare markets. The company features several key technologies: its "Linebacker" platform utilizes small molecule electrophilically enhanced polyphenol compounds with potential applications in treating cancer, inflammatory diseases, and neurological conditions.
Valuation Ratios
| Price / Book | 4.56 |
| EV / EBITDA | -132.72 |
| Dividend Yield | 0.00% |
Income Statement (10y)
| Year | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | 0 | $50000 | $50000 | 0 | 0 | $32000 |
| Cost of Revenue | 0 | 0 | 0 | 0 | 0 | $424000 |
| Gross Profit | 0 | $50000 | $50000 | 0 | 0 | -$392000 |
| Research & Development | $513692 | $1.2M | $1.2M | $1.7M | $278000 | $340000 |
| Selling, General & Admin | $383034 | $1.0M | $1.0M | $1.1M | $1.8M | $2.0M |
| Operating Expenses | $896727 | $3.5M | $3.5M | $4.0M | $28.8M | $3.9M |
| Operating Income | -$896727 | -$3.4M | -$3.4M | -$4.0M | -$28.8M | -$4.3M |
| EBITDA | -$896727 | -$6.3M | -$6.3M | -$2.8M | -$22.6M | -$12.5M |
| Interest Expense | 0 | $300000 | $462000 | $444000 | $117401 | $793000 |
| Pre-tax Income | -$896727 | -$7.9M | -$7.9M | -$4.4M | -$24.7M | -$14.4M |
| Income Tax | -$82000 | -$621000 | -$621000 | 0 | $33000 | -$2.6M |
| Net Income | -$597342 | -$7.1M | -$7.1M | -$4.3M | -$24.7M | -$11.8M |
| EPS | $-0.05 | $-0.61 | $-0.61 | $-0.07 | $-0.01 | $-0.38 |
| EPS (Diluted) | $-0.05 | $-0.61 | $-0.61 | $-0.07 | $-0.01 | $-0.38 |
| Shares Outstanding (Diluted) | $11.5M | $11.5M | $11.5M | $60.2M | $41.8M | $31.6M |
Price
| Price | $0.50 |
| Market Cap | $54M |
| Exchange | AMEX |
| Country | US |
Related companies: ADIL · AIM · BCLI · CYCN · MLEC · NRSN · QNRX
Explore sector: Healthcare · Biotechnology
More sections of IBO: Overview · Financials · Valuation · Statistics · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks